Advertisement
Screener

ARDELYX, INC. (ARDX) Authorized Dilution

ARDELYX, INC. Authorized Dilution

Share-issuance capacity and approved equity plans, with the disclosed share class, period, approval and expiry. Gross charter headroom is authorized minus issued shares, not a forecast. Equity plan reserves may use weighted counting rules, overlap charter capacity, and must not be added to it. Outstanding awards, future grants, and proposed approvals are distinct. * denotes calculated capacity.

As ofAuthorization / planShare classAuthorized / approved limit (shares)Issued shares / outstanding awards (shares)Remaining capacity (shares / reserve units)Approval statusApproval dateExpiry / conditionsBasis / limitationsSource

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Apnimed, Inc. (APMD)United States$0.899B
GERON CORP (GERN)United States$0.803B-12.14